Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
Journal of Hepato-Biliary-Pancreatic Sciences|September 7, 2020
Branched-chain amino acid to tyrosine ratio is an essential pre-treatment factor for maintaining sufficient treatment intensity of lenvatinib in patients with hepatocellular carcinomaYuji Eso, Shigeharu Nakano, Masako Mishima, et al.
SAGE Open Medical Case Reports|February 25, 2021
Thoracic spondylotic myelopathy presumably caused by diffuse idiopathic skeletal hyperostosis in a patient who underwent decompression and percutaneous pedicle screw fixationShota Miyoshi, Tadao Morino, Haruhiko Takeda, et al.
Scientific Reports|December 26, 2018
Expansion of viral variants associated with immune escape and impaired virion secretion in patients with HBV reactivation after resolved infectionTadashi Inuzuka, Yoshihide Ueda, Soichi Arasawa, et al.
Internal Medicine (Tokyo, Japan)|March 18, 2014
Prominent hypereosinophilia with disseminated intravascular coagulation as an unusual presentation of advanced gastric cancerHaruhiko Takeda, Hiroki Nishikawa, Takehiko Tsumura, et al.
Quantitative Imaging in Medicine and Surgery|June 3, 2021
A simplified method to quantitatively predict the effect of lenvatinib on hepatocellular carcinoma using contrast-enhanced ultrasound with perfluorobutane microbubblesYuji Eso, Shigeharu Nakano, Masako Mishima, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 13, 2015
Proposal of Japan Red Cross score for sorafenib therapy in hepatocellular carcinomaHaruhiko Takeda, Hiroki Nishikawa, Yukio Osaki, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|March 31, 2021
Mac-2 binding protein glycosylation isomer predicts tolerability and clinical outcome of lenvatinib therapy for hepatocellular carcinomaYuji Eso, Shigeharu Nakano, Masako Mishima, et al.
Scientific Reports|December 5, 2020
DNA methyltransferase 3B plays a protective role against hepatocarcinogenesis caused by chronic inflammation via maintaining mitochondrial homeostasisEriko Iguchi, Atsushi Takai, Haruhiko Takeda, et al.
Journal of Cancer|June 26, 2014
Sorafenib Therapy for BCLC Stage B/C Hepatocellular Carcinoma; Clinical Outcome and Safety in Aged Patients: A Multicenter Study in JapanHiroki Nishikawa, Haruhiko Takeda, Kaoru Tsuchiya, et al.
Scientific Reports|June 2, 2026
True reactivation versus transient viremia: a retrospective analysis of HBV reactivation in resolved infectionTadashi Inuzuka, Atsushi Takai, Masayuki Ueno, et al.
Pageof 8